Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 472.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000004 (????)	F. Tison [France] ; J. Lecaroz ; L. Letenneur ; J F Dartigues	Parkinsonism and exposure to neuroleptic drugs in elderly people living in institutions.
000010 (1999)	F. Durif [France] ; M. Vidailhet ; B. Debilly ; Yves Agid [France]	Worsening of levodopa-induced dyskinesias by motor and mental tasks.
000011 (1999)	J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. Malbezin	A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
000012 (1999)	L. Defebvre [France] ; P. Derambure ; J L Bourriez ; A. Destée ; J D Guieu	[Event-related desynchronization and Parkinson disease. Importance in the analysis of the phase of preparation for movement].
000013 (1998)		Ropinirole: new preparation. Wait for more convincing data.
000020 (1999)	B P Bejjani [France] ; P. Damier ; I. Arnulf ; L. Thivard ; A M Bonnet ; D. Dormont ; P. Cornu ; B. Pidoux ; Y. Samson ; Yves Agid [France]	Transient acute depression induced by high-frequency deep-brain stimulation.
000021 (1999)	O. Rascol [France]	Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?
000027 (1999)	P. Krack [France] ; P. Pollak ; P. Limousin ; A. Benazzouz ; G. Deuschl ; A L Benabid	From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
000028 (1999)	O. Rascol [France] ; O. Blin ; C. Thalamas ; S. Descombes ; C. Soubrouillard ; P. Azulay ; N. Fabre ; F. Viallet ; K. Lafnitzegger ; S. Wright ; J H Carter ; J G Nutt	ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease.
000036 (1999)	O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L Montastruc	Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
000037 (1999)	P. Damier [France]	New aspects in the pathophysiology of dyskinesia. Salpêtrière Deep Brain Stimulation Group.
000042 (1999)	C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. Rascol	Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
000047 (????)	H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L Montastruc	A study of salivary secretion in Parkinson's disease.
000056 (1999)	Yves Agid [France]	Parkinson's disease or Parkinson's diseases?
000061 (1999)	M. Vidailhet [France] ; A M Bonnet ; R. Marconi ; F. Durif ; Yves Agid [France]	The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
000062 (1999)	O. Rascol [France]	L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
000064 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.
000073 (1999)	M. Gentil [France] ; C L Tournier ; P. Pollak ; A L Benabid	Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
000074 (1999)	S. Champagne [France] ; E. Coste ; H. Peyrière ; J. Nigond ; E. Mania ; M. Pons ; D. Hillaire-Buys ; P. Balmes ; J P Blayac ; J M Davy	Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
000079 (1999)	E. Bezard [France] ; C. Brefel ; F. Tison ; H. Peyro-Saint-Paul ; P. Ladure ; O. Rascol ; C E Gross	Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.
000080 (1999)	Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. Tolosa	Levodopa in the treatment of Parkinson's disease: a consensus meeting.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024